Zinc deficiency exaggerates diabetic osteoporosis

Area of Science:

• Endocrinology
• Bone Biology
• Nutritional Science

Background:

• Diabetes mellitus is associated with increased fracture risk and bone fragility.
• Osteoporosis is a significant complication of diabetes, impacting bone microarchitecture and mineral content.
• The role of micronutrients, such as zinc, in diabetes-related bone disease requires further elucidation.

Purpose of the Study:

• To investigate the impact of mild zinc deficiency on bone fragility and mineral metabolism in streptozotocin-induced diabetic rats.
• To determine the efficacy of insulin treatment in reversing diabetes-induced osteoporosis and the influence of zinc deficiency on this reversal.
• To analyze the effects of combined diabetes and zinc deficiency on bone cortical thickness and mineral excretion.

Main Methods:

• Induction of diabetes in rats using streptozotocin.
• Feeding rats with either a zinc-deficient or control diet.
• Assessment of bone fragility using mechanical testing.
• Microscopic examination of tibial cortical bone.
• Measurement of serum and urinary calcium and phosphorus levels.
• Evaluation of insulin treatment efficacy.

Main Results:

• Streptozotocin-induced diabetes led to increased bone fragility and thinner tibial cortical bone, indicative of osteoporosis.
• Insulin treatment normalized bone fragility in diabetic rats.
• Mild zinc deficiency did not alter serum zinc levels but reduced bone calcium content in diabetic rats.
• Zinc deficiency significantly increased urinary calcium and phosphorus excretion and decreased bone mineral concentrations, effects not reversed by insulin.
• Combined diabetes and zinc deficiency markedly enhanced skeletal changes.

Conclusions:

• Osteoporosis in diabetic rats is characterized by cortical thinning and mineral loss, which is reversible by insulin treatment.
• Mild zinc deficiency exacerbates skeletal deterioration in diabetic rats, suggesting a synergistic negative effect on bone health.
• The detrimental effects of zinc deficiency on bone metabolism in diabetes are not fully reversed by insulin therapy.